Literature DB >> 17222991

Amphetamine affects the start of responding in the peak interval timing task.

Kathleen M Taylor1, Jon C Horvitz, Peter D Balsam.   

Abstract

In this paper we investigate how amphetamine affects performance in a PI task by comparing two analyses of responding during peak trials. After training on 24 s fixed interval (FI-24) with 96 s peak trials, rats were given amphetamine for 4 consecutive days at doses of .5 and 1.0 mg/kg. Responses during peak trials were fitted with a Gaussian distribution to estimate the expected time of reinforcement from the peak time. A single trials analysis was also performed to determine the start time and stop time of the transition into and out of a high rate of responding on each peak trial. Amphetamine significantly decreased peak times as measured with the Gaussian curve fitting. However, in the single trials analysis, animals initiated responding significantly earlier, but did not stop responding earlier. Thus, fitting a Gaussian to the average performance across trials sometimes provides a different characterization of the timing process than does analyzing the start and stop of responding on individual trials. In the current experiment, the latter approach provided a more precise characterization of the effects of amphetamine on response timing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17222991     DOI: 10.1016/j.beproc.2006.11.005

Source DB:  PubMed          Journal:  Behav Processes        ISSN: 0376-6357            Impact factor:   1.777


  30 in total

1.  The effect of changes in criterion value on differential reinforcement of low rate schedule performance.

Authors:  Matthew J Pizzo; Kimberly Kirkpatrick; Pamela J Blundell
Journal:  J Exp Anal Behav       Date:  2009-09       Impact factor: 2.468

2.  Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.

Authors:  Erik B Oleson; Michael V Beckert; Joshua T Morra; Carien S Lansink; Roger Cachope; Rehab A Abdullah; Amy L Loriaux; Dustin Schetters; Tommy Pattij; Mitchell F Roitman; Aron H Lichtman; Joseph F Cheer
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

3.  Frontal brain injury chronically impairs timing behavior in rats.

Authors:  Taylor L Scott; Cole Vonder Haar
Journal:  Behav Brain Res       Date:  2018-09-10       Impact factor: 3.332

4.  Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.

Authors:  Joost Wiskerke; Nicky Stoop; Dustin Schetters; Anton N M Schoffelmeer; Tommy Pattij
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

5.  D1-dependent 4 Hz oscillations and ramping activity in rodent medial frontal cortex during interval timing.

Authors:  Krystal L Parker; Kuan-Hua Chen; Johnathan R Kingyon; James F Cavanagh; Nandakumar S Narayanan
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

6.  Phase resetting and its implications for interval timing with intruders.

Authors:  Sorinel A Oprisan; Steven Dix; Catalin V Buhusi
Journal:  Behav Processes       Date:  2013-10-07       Impact factor: 1.777

7.  Interval timing under a behavioral microscope: Dissociating motivational and timing processes in fixed-interval performance.

Authors:  Carter W Daniels; Federico Sanabria
Journal:  Learn Behav       Date:  2017-03       Impact factor: 1.986

8.  Nicotine does not enhance discrimination performance in a temporal bisection procedure.

Authors:  Ryan D Ward; Scott T Barrett; Robert N Johnson; Amy L Odum
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

9.  Acquisition of peak responding: what is learned?

Authors:  Fuat Balci; Charles R Gallistel; Brian D Allen; Krystal M Frank; Jacqueline M Gibson; Daniela Brunner
Journal:  Behav Processes       Date:  2008-10-04       Impact factor: 1.777

Review 10.  Temporal memory averaging and post-encoding alterations in temporal expectation.

Authors:  Matthew S Matell; Alexandra M Henning
Journal:  Behav Processes       Date:  2013-02-27       Impact factor: 1.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.